|
| |
Xerion Pharmaceuticals GmbH Pages on BioPortfolio:
XERION PHARMACEUTICALS appointed anil singhal, Ph.D.,
13 May 2003 ... Dr. Singhal will be based at Xerion Pharmaceuticals Inc. in Cambridge, ... Technology Ltd., Procorde GmbH, and several research institutes. ...
http://www.bioportfolio.com/news/xerion_4.htm...
|
BioPortfolio - BioPortfolio - Xerion Pharmaceuticals GmbH
BioPortfolio - Xerion Pharmaceuticals GmbH - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/11099/www.x...
|
XERION PHARMACEUTICALS ENTERS INTO OPTION AGREEMENT FOR CANCER ...
Xerion Pharmaceuticals is building a pipeline of novel therapeutic targets and ... Arius Research Inc., Cambridge Antibody Technology Ltd., Procorde GmbH, ...
http://www.bioportfolio.com/news/xerion_3.htm...
|
BioPortfolio - Biocorporate Search Martinsried
Xerion Pharmaceuticals GmbH. Xerion's proprietary protein/ligand identification technology platform, Xcelerate, focuses on the combination of proteome-wide ...
http://www.bioportfolio.com/biocorporate/search/city/Martins...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug .... Biomedical systems | Aabio GmbH | Upstate Biotechnology Incorporated ...
http://www.bioportfolio.com/bookshop/search/Mulibrey+Nanism/...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/bookshop/Operation/ItemSearch/Se...
|
BioPortfolio BioNews (News & Press Releases) October 02
Co-operation with AnalytiCon Discovery GmbH ... XERION PHARMACEUTICALS AND ARIUS RESEARCH SIGN COLON CANCER COLLABORATION ...
http://www.bioportfolio.com/news/oct_02.htm...
|
Post-Genomic Target Validation
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... Timothy Hoey, Tularik; Leodevico L. Ilag, Xerion Pharmaceuticals AG; ...
http://www.bioportfolio.com/reports/Post-Genomic%20Target%20...
|
BioPortfolio BioNews (News & Press Releases) July 2003
Xerion Pharmaceuticals and Xoma sign licensing agreement · New Deal for Biochrom in USA ... Synbiosis - Oxoid GmbH Chooses ProtoCOL ...
http://www.bioportfolio.com/news/july_03.htm...
|
BioPortfolio BioNews (News & Press Releases) February 2003
XERION PHARMACEUTICALS ENTERS INTO OPTION AGREEMENT FOR CANCER TARGETS FROM TUFTS UNIVERSITY ... Mediatum GmbH Turning Visions into Capital ...
http://www.bioportfolio.com/news/feb_03.htm...
|
Results from other life science and pharmaceutical sites:
Xerion Pharma
Xerion Pharma. Website Update in progress. Website Development & Target Marketing by Domatica Web & IT Services. Domatica company news on ...
http://www.xerion-pharma.com/...
|
XERION PHARMACEUTICALS appointed anil singhal, Ph.D.,
13 May 2003 ... Dr. Singhal will be based at Xerion Pharmaceuticals Inc. in Cambridge, ... Technology Ltd., Procorde GmbH, and several research institutes. ...
http://www.bioportfolio.com/news/xerion_4.htm...
|
BioSpace - Xerion Pharmaceuticals News, Search Jobs, Events
Xerion Pharmaceuticals AG Sauerbruchstrasse 50 Munich 81377 Germany ... Xerion Pharmaceuticals And Stemline Therapeutics Announce Collaboration On Cancer ...
http://www.biospace.com/company_profile.aspx?CompanyId=82904...
|
BioPortfolio - BioPortfolio - Xerion Pharmaceuticals GmbH
BioPortfolio - Xerion Pharmaceuticals GmbH - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/11099/www.x...
|
Medarex and Xerion Announce Antibody Deal
About Xerion Pharmaceuticals Xerion Pharmaceuticals is building a pipeline of novel therapeutic targets and antibodies in the indications of cancer and ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
XERION PHARMACEUTICALS ENTERS INTO OPTION AGREEMENT FOR CANCER ...
Xerion Pharmaceuticals is building a pipeline of novel therapeutic targets and ... Arius Research Inc., Cambridge Antibody Technology Ltd., Procorde GmbH, ...
http://www.bioportfolio.com/news/xerion_3.htm...
|
Advances in Target Validation - SMi 2nd Annual Conference ...
Xerion Pharmaceuticals GmbH. Fraunhoferstrasse 9. D-82152 Martinsried (Munich). Germany. Email: lilag@xerion-pharma.com. IDrugs 2002 5(6):557-561 ...
http://www.biomedcentral.com/content/pdf/cd-457693.pdf...
|
BioPortfolio - Biocorporate Search GmBH
Xerion Pharmaceuticals GmbH. Xerion's proprietary protein/ligand identification technology platform, Xcelerate, focuses on the combination of proteome-wide ...
http://www.bioportfolio.com/biocorporate/GmBH-companies.htm-...
|
Genomics and proteomics tools for the clinic.
Xerion Pharmaceuticals GmbH, Fraunhoferstr 9, D-82152, Martinsried/Munich, Germany. f.rudert@xerion-pharma.com. The sequencing of the human genome was only
...
http://www.ncbi.nlm.nih.gov/pubmed/11249740...
|
Drug Discovery Technology Europe 2004 - IBC's Eighth Annual ...
Vic Ilag (Xerion Pharmaceuticals GmbH, Germany). suggested that there is a bottleneck in finding the right drug. for the right target, and that the current
...
http://www.biomedcentral.com/content/pdf/cd-528879.pdf...
|
|
